Balance Sheet Data
Rigel Pharmaceuticals, Inc. (RIGL)
$1.325
+0.18 (+16.23%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 128.54 | 98.08 | 57.33 | 124.97 | 58.21 | 205.34 | 274.32 | 366.47 | 489.59 | 654.06 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 4.08 | 10.11 | 15.97 | 15.47 | 40.32 | 27.25 | 36.40 | 48.63 | 64.97 | 86.80 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.89 | 1.35 | 1.64 | 6.62 | 9.12 | 5.72 | 7.65 | 10.22 | 13.65 | 18.23 |
| Inventories (%) | ||||||||||
| Accounts Payable | 6.39 | 4.15 | 3.71 | 3.79 | 22.51 | 14.79 | 19.76 | 26.40 | 35.26 | 47.11 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -1.11 | -1.45 | -1.26 | -0.63 | -0.45 | -2.22 | -2.96 | -3.95 | -5.28 | -7.06 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.